Navigation Links
ISTA Pharmaceuticals Receives Action Date for FDA Review of Once-Daily XiDay(TM)
Date:3/8/2010

m/.

Xibrom (bromfenac ophthalmic solution)® 0.09%, and XiDay™ are trademarks of ISTA Pharmaceuticals.

Forward-looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements.  Without limiting the foregoing, but by way of example, statements contained in this press release related to ISTA's belief that the FDA is considering a shorter review time of six months for XiDay, and ISTA's expectation of becoming the leading niche ophthalmic pharmaceutical company are forward-looking statements.  Except as required by law, ISTA disclaims any intent or obligation to update any forward-looking statements.  These forward-looking statements are based on ISTA's expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially.  Important factors that could cause actual results to differ from current expectations include, among others, delays and uncertainties related to the FDA or other regulatory agency approval or actions and such other risks and uncertainties as detailed from time to time in ISTA's public filings with the U.S. Securities and Exchange Commission, including but not limited to ISTA's Annual Report on Form 10-K for the year en
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014  - MediaLINC ... Today Lincor announced general availability of MediaLINC ... a range of education, entertainment and clinical content direct ... http://photos.prnewswire.com/prnh/20140822/702945) , " Lincor has ... patient engagement to bedside smart devices, " comments ...
(Date:8/22/2014)... , Aug. 22, 2014  Landauer, Inc. (NYSE: ... environmental radiation measurement and monitoring, outsourced medical physics services ... William E. Saxelby , its President and Chief ... Chief Executive Officer and as a member of the ... He will be replaced on an interim basis by ...
(Date:8/22/2014)... , Aug. 22, 2014  WaferGen Bio-systems, Inc. ... public offering of units of common stock and warrants ... proceeds of $20 million, prior to deducting underwriting discounts ... The shares and warrants are immediately separable and will ... expected to begin trading on The NASDAQ Stock Market ...
Breaking Medicine Technology:Lincor Unveils Next Generation TV-based Patient Engagement Solution 2Landauer, Inc. Announces Executive Management Change 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4
... Dec. 29, 2010 Reportlinker.com announces that a new ... Mammography World Markets ... poised for a major new phase of growth fueled ... the computer and digital areas and the higher interest ...
... (Nasdaq: OMER ), a biopharmaceutical company ... on inflammation and disorders of the central nervous ... clinical trial of OMS201, the Company,s urological PharmacoSurgery™ ... an anti-inflammatory agent and a smooth muscle relaxant, ...
Cached Medicine Technology:Reportlinker Adds Mammography World Markets 2Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy 2Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy 3
(Date:8/22/2014)... August 22, 2014 The New Jersey ... at Rutgers, the State University of New Jersey has ... children’s media organization, to educate young people about health ... on the strengths of both organizations. , The partnership ... health communications fellowship program, and video communications. ChopChop ...
(Date:8/22/2014)... Dennis Thompson ... News) -- The two American health-care workers infected with ... in West Africa have been released from the Atlanta ... weeks, officials said Thursday. Dr. Kent Brantly, 33, ... Nancy Writebol left the hospital Tuesday. Her family said ...
(Date:8/22/2014)... The leather seat covers provided by Lseat.comare meticulously ... customers’specific product needs. Recently, the company has unveiled its latest ... The company wants to provide worldwide clients with more high ... industry for a long time. According to the company’s sales ... rates. Among all the new products, Chevrolet Camaro leather ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Lincolnshire Marriott ... their meetings with a tap, announcing Marriott’s new iPad ... take advantage of this exclusive offer will receive a ... and set up the day’s agenda with ease. Marriott’s ... make on-the-fly changes and connect with their group with ...
(Date:8/22/2014)... 22, 2014 Minorities in Orange and Los ... comes to mental health and recovery from trauma. Casa de ... the gap between local minorities and the help they need. ... by making the connection between mental and physical health. , ... at their fitness boot camp, located at 16560 Harbor Blvd., ...
Breaking Medicine News(10 mins):Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 2Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 3Health News:Both U.S. Health-Care Workers Infected With Ebola Released From Hospital 2Health News:Both U.S. Health-Care Workers Infected With Ebola Released From Hospital 3Health News:Custom 1993-1996 Chevrolet Camaro Leather Seat Covers Now for Sale at Lseat.com 2Health News:Lincolnshire Marriott Resort Offers iPad Mini for Chicago Meeting Planners 2Health News:Fountain Valley Fit Body Boot Camp Announces Fitness Boot Camp Fundraising Event for Casa de Familia 2Health News:Fountain Valley Fit Body Boot Camp Announces Fitness Boot Camp Fundraising Event for Casa de Familia 3
... to get the right information about product,risks and ... MEETING, Pa., June 4 ECRI,Institute, (http://www.ecri.org ... approaches to improving patient care, has enhanced its,Alerts ... coverage of healthcare products and new alert filters., ...
... 4 Unilens Vision Inc. (OTC,Bulletin Board: ... manufactures, distributes and markets specialty contact lenses,today ... Unilens GP (Gas Permeable),products., Unilens, known ... Lens,Company", continues its tradition of providing outstanding ...
... MOUNTAINSIDE, N.J., June 4 L&M Healthcare,Communications LLC, ... of a new full-service Midwest office in Milwaukee,Wis. ... President, Client Services., These enhancements allow L&M ... meet the needs of their growing client,portfolio. Todd ...
... WASHINGTON, June 4 As talk of ... sales bring up,worries about the nation,s economic health, ... are stressed and anxious about,their financial future. An ... that,two-thirds (66 percent) of Americans identify the economy ...
... AstraZeneca (NYSE: AZN) today announced that it submitted ... Food and Drug Administration (FDA) for approval of a ... for the long-term maintenance treatment of asthma in pediatric ... currently approved for the long-term maintenance treatment of asthma ...
... in two health surveys carried out a year apart admitted ... latest Journal of Advanced Nursing. , Thirteen per cent admitted ... a further five per cent reported problems in both surveys. ... to report multiple psychological problems and health complaints. , ...
Cached Medicine News:Health News:ECRI Institute's Alert and Recall Management System Expands Effectiveness with New Content and Filters 2Health News:Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability 2Health News:L&M Healthcare Communications LLC Expands With Hiring of New Executive Staff & Opening of Midwest Office 2Health News:Economy and Money Top Causes of Stress for Americans 2Health News:Economy and Money Top Causes of Stress for Americans 3Health News:AstraZeneca submits an sNDA for Symbicort for treatment of asthma in children as young as 6 2Health News:Nearly 1 in 5 teenagers admit eating problems, but anxiety is a bigger problem than appearance 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: